Asia, key destination for clinical trials
Due to unique regional features, conducting clinical trials in Asia can provide benefits such as a faster recruitment process, high quality equivalent data and an interesting cost scenario. Despite these opportunities, there are challenges related to diverse regulatory environments, legal issues, language and cultural hurdles, which makes essential to partner with an expert CRO.
Originally established in Japan, Linical is a global CRO which has actively expanded to become the first Japanese Headquartered CRO capable of delivering a one-stop service for large-scale projects, covering all key markets in Asia-Pacific. Linical has the experience, resources and know-how to successfully overcome the unique challenges of conducting clinical trials in Asia:
- More than 600 expert professionals located in Asia.
- 7 offices in main Asian markets.
- More than 15-year experience in the region.
- Deep local regulatory knowledge.
- Excellent relationship with sites, KOLs and PIs.
A Global CRO with a strong footprint in Asia
We offer our full-service capabilities and global reach but with an in-depth country specific expertise to ensure the success of clinical trials in main Asian territories
The right partner for clinical trials in Asia
Combining a global business approach with specific clinical and regulatory expertise our team provides flexibility, guidance and key strategies to avoid obstacles and optimize clinical trials in Asia.
Interested in accessing the Japanese Market?
Linical can support Biotech and pharma companies interested in entering Japanese market but unfamiliar with its regulations. Check out our solutions a successful access to Japan’s Pharma market
Resources
Get access to top quality content from our experts. Go to these related posts: